Parsatuzumab (Anti-EGFL7)
Parsatuzumab (Anti-EGFL7) is a humanized monoclonal antibody targeting EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition. MW: 145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2515 |
| Sku # | A2515-1mg*5 |
| Pricing | 1mg*5, $790.00 |